“…It is therefore remarkable here that the overall genome-wide level of APOBEC3 signature mutation from A3A is only ~4-fold higher than that attributable to A3B. Endogenous A3A and A3B also have both distinct and overlapping transcription programs, and both genes can be induced by a variety of conditions including viral infection and inflammation (Argyris et al, 2020; Cho et al, 2018; Leonard et al, 2015; Maruyama et al, 2016; Oh et al, 2021; Periyasamy et al, 2015; Periyasamy et al, 2017; Roelofs et al, 2020; Starrett et al, 2019; Verhalen et al, 2016; Vieira et al, 2014; Warren, Westrich, Doorslaer, & Pyeon, 2017; Warren et al, 2015; Westrich et al, 2018). In vivo , A3A and A3B gene expression is also likely to be affected by the local tumor microenvironment, which can vary both between and within cancer types, as well as by a patient’s global state of health.…”